A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening condition characterized with microangiopathic hemolytic anemia, thrombocytopenia, fever, neurological findings, and renal failure. The standard treatment of TTP is plasma exchange and corticosteroids; however, many patients require additional immunosuppression. In this article, we present a refractory TTP case that did not respond to a treatment of daily two doses of plasma exchange and corticosteroid, and that recovered rapidlydoi:10.5606/fng.btd.2017.014 fatcat:oeunqdrivzdhbjx4qmbiqmtivq